144 related articles for article (PubMed ID: 36161804)
1. Design, synthesis, and structure-activity relationship of caffeine-based triazoles as dual AChE and BACE-1 inhibitors.
Sharma M; Sharma A; Nuthakki VK; Bhatt S; Nandi U; Bharate SB
Drug Dev Res; 2022 Dec; 83(8):1803-1821. PubMed ID: 36161804
[TBL] [Abstract][Full Text] [Related]
2. Discovery of blood-brain barrier permeable and orally bioavailable caffeine-based amide derivatives as acetylcholinesterase inhibitors.
Sharma M; Sharma A; Thakur S; Nuthakki VK; Jamwal A; Nandi U; Jadhav HR; Bharate SB
Bioorg Chem; 2023 Oct; 139():106719. PubMed ID: 37473478
[TBL] [Abstract][Full Text] [Related]
3. Multitargeted C9-substituted ester and ether derivatives of berberrubine for Alzheimer's disease: Design, synthesis, biological evaluation, metabolic stability, and pharmacokinetics.
Raghuvanshi R; Jamwal A; Nandi U; Bharate SB
Drug Dev Res; 2023 Feb; 84(1):121-140. PubMed ID: 36461610
[TBL] [Abstract][Full Text] [Related]
4. Blood-brain barrier permeable benzylpiperidin-4-yl-linked benzylamino benzamides as dual cholinesterase inhibitors.
Banoo R; Nuthakki VK; Abdullaha M; Sharma M; Bharate SB
Drug Dev Res; 2022 Dec; 83(8):1791-1802. PubMed ID: 36112736
[TBL] [Abstract][Full Text] [Related]
5. A Coumarin-Donepezil Hybrid as a Blood-Brain Barrier Permeable Dual Cholinesterase Inhibitor: Isolation, Synthetic Modifications, and Biological Evaluation of Natural Coumarins.
Sharma A; Nuthakki VK; Gairola S; Singh B; Bharate SB
ChemMedChem; 2022 Sep; 17(18):e202200300. PubMed ID: 35892288
[TBL] [Abstract][Full Text] [Related]
6. Identification of aplysinopsin as a blood-brain barrier permeable scaffold for anti-cholinesterase and anti-BACE-1 activity.
Nuthakki VK; Yadav Bheemanaboina RR; Bharate SB
Bioorg Chem; 2021 Feb; 107():104568. PubMed ID: 33418314
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of novel quinazoline-triazole hybrid compounds with potential use in Alzheimer's disease.
Le-Nhat-Thuy G; Nguyen Thi N; Pham-The H; Dang Thi TA; Nguyen Thi H; Nguyen Thi TH; Nguyen Hoang S; Nguyen TV
Bioorg Med Chem Lett; 2020 Sep; 30(18):127404. PubMed ID: 32717612
[TBL] [Abstract][Full Text] [Related]
8. New coumarin-benzotriazole based hybrid molecules as inhibitors of acetylcholinesterase and amyloid aggregation.
Singh A; Sharma S; Arora S; Attri S; Kaur P; Kaur Gulati H; Bhagat K; Kumar N; Singh H; Vir Singh J; Mohinder Singh Bedi P
Bioorg Med Chem Lett; 2020 Oct; 30(20):127477. PubMed ID: 32781220
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Biological Evaluation of Coumarin Triazoles as Dual Inhibitors of Cholinesterases and β-Secretase.
Sharma A; Bharate SB
ACS Omega; 2023 Mar; 8(12):11161-11176. PubMed ID: 37008108
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and biological evaluation of ferulic acid based 1,3,4-oxadiazole hybrids as multifunctional therapeutics for the treatment of Alzheimer's disease.
Tripathi A; Choubey PK; Sharma P; Seth A; Saraf P; Shrivastava SK
Bioorg Chem; 2020 Jan; 95():103506. PubMed ID: 31887472
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of donepezil analogues as dual AChE and BACE-1 inhibitors.
Gabr MT; Abdel-Raziq MS
Bioorg Chem; 2018 Oct; 80():245-252. PubMed ID: 29966870
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Acetylcholinesterase by Novel Lupinine Derivatives.
Schepetkin IA; Nurmaganbetov ZS; Fazylov SD; Nurkenov OA; Khlebnikov AI; Seilkhanov TM; Kishkentaeva AS; Shults EE; Quinn MT
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110594
[TBL] [Abstract][Full Text] [Related]
13. Novel tacrine-1,2,3-triazole hybrids: In vitro, in vivo biological evaluation and docking study of cholinesterase inhibitors.
Najafi Z; Mahdavi M; Saeedi M; Karimpour-Razkenari E; Asatouri R; Vafadarnejad F; Moghadam FH; Khanavi M; Sharifzadeh M; Akbarzadeh T
Eur J Med Chem; 2017 Jan; 125():1200-1212. PubMed ID: 27863370
[TBL] [Abstract][Full Text] [Related]
14. 5,6-Diphenyl triazine-thio methyl triazole hybrid as a new Alzheimer's disease modifying agents.
Yazdani M; Edraki N; Badri R; Khoshneviszadeh M; Iraji A; Firuzi O
Mol Divers; 2020 Aug; 24(3):641-654. PubMed ID: 31327094
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of indoloquinoline alkaloid cryptolepine and its bromo-derivative as dual cholinesterase inhibitors.
Nuthakki VK; Mudududdla R; Sharma A; Kumar A; Bharate SB
Bioorg Chem; 2019 Sep; 90():103062. PubMed ID: 31220673
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of novel chromenones linked to 1,2,3-triazole ring system: Investigation of biological activities against Alzheimer's disease.
Saeedi M; Safavi M; Karimpour-Razkenari E; Mahdavi M; Edraki N; Moghadam FH; Khanavi M; Akbarzadeh T
Bioorg Chem; 2017 Feb; 70():86-93. PubMed ID: 27914694
[TBL] [Abstract][Full Text] [Related]
17. Further SAR studies on natural template based neuroprotective molecules for the treatment of Alzheimer's disease.
Singh YP; Shankar G; Jahan S; Singh G; Kumar N; Barik A; Upadhyay P; Singh L; Kamble K; Singh GK; Tiwari S; Garg P; Gupta S; Modi G
Bioorg Med Chem; 2021 Sep; 46():116385. PubMed ID: 34481338
[TBL] [Abstract][Full Text] [Related]
18. Tyrosol 1,2,3-triazole analogues as new acetylcholinesterase (AChE) inhibitors.
Bousada GM; de Sousa BL; Furlani G; Agrizzi AP; Ferreira PG; Leite JPV; Mendes TAO; Varejão EVV; Pilau EJ; Dos Santos MH
Comput Biol Chem; 2020 Oct; 88():107359. PubMed ID: 32853899
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.
Kwon YE; Park JY; No KT; Shin JH; Lee SK; Eun JS; Yang JH; Shin TY; Kim DK; Chae BS; Leem JY; Kim KH
Bioorg Med Chem; 2007 Oct; 15(20):6596-607. PubMed ID: 17681794
[TBL] [Abstract][Full Text] [Related]
20. Novel tacrine-based acetylcholinesterase inhibitors as potential agents for the treatment of Alzheimer's disease: Quinolotacrine hybrids.
Sadafi Kohnehshahri M; Chehardoli G; Bahiraei M; Akbarzadeh T; Ranjbar A; Rastegari A; Najafi Z
Mol Divers; 2022 Feb; 26(1):489-503. PubMed ID: 34491490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
